Merilog 100units/mL is supplied as both a 10mL multi-dose vial as well as a 3mL single-patient-use prefilled pen. The Food and Drug Administration (FDA) has approved Merilog (insulin-aspart-szjj), a ...

The US Food and Drug Administration (FDA) has cleared the Bigfoot Unity Diabetes Management System, a cap device that connects to insulin pens and translates continuous glucose data into dosing ...

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently approved Merilog (insulin-aspart-szjj) as the first ...

Technological advancements in insulin pens, pumps, and continuous glucose monitoring systems have greatly improved the convenience and effectiveness of rapid acting insulin. Current delivery devices ...

The Bigfoot Unity System uses iCGM data from Abbott’s FreeStyle Libre 2 system and consists of smart pen caps for rapid- and long-acting insulin, as well as a mobile app. The Food and Drug ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced Friday. Like its reference ...

Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "United States Rapid Acting Insulin Market Report by Product, Indication, Distribution Channel, States and Company Analysis, 2025-2033" report has been ...

The U.S. Food and Drug Administration (FDA) has approved Merilog, a biosimilar to the widely used insulin product Novolog (insulin aspart), to enhance glycemic control in adults and children with ...

As a rapid-acting insulin, Merilog helps lower mealtime blood sugar spikes and improve blood sugar control in people with diabetes. The approval is for a 3 milliliter (mL) single-patient-use prefilled ...